Risk Paradigm Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,650
| Closed | -$77K | – | 113 |
|
|
2018
Q1 | $77K | Buy |
2,650
+700
| +36% | +$20.3K | 0.1% | 126 |
|
|
2017
Q4 | $46.4K | Buy |
+1,950
| New | +$46.4K | 0.05% | 164 |
|
|
2017
Q3 | – | Sell |
-700
| Closed | -$16.1K | – | 237 |
|
|
2017
Q2 | $16.1K | Buy |
+700
| New | +$16.1K | 0.02% | 204 |
|